Medicine & Health

Hypothesis

In senescent cells, protein aggregates function as a protective sink that sequesters pro‑apoptotic BH3‑only proteins (e.g., BIM, PUMA, NOXA) through hydrophobic interactions with amyloid‑like surfaces. This sequestration raises the threshold for mitochondrial outer membrane permeabilization (MOMP) by limiting the availability of BH3‑only activators that can neutralize anti‑apoptotic Bcl‑2 family members. The senescent‑cell‑specific upregulation of the NRF2‑Bcl‑2 transcriptional axis not only boosts anti‑apoptotic Bcl‑2, Bcl‑xL and MCL‑1 but also drives chaperone‑mediated aggregation, coupling proteostasis stress to survival dependence. Consequently, disrupting aggregates should liberate sequestered BH3‑only proteins, lower the apoptotic priming threshold, and render senescent cells exquisitely sensitive to Bcl‑2/MCL‑1 inhibitor combinations at sub‑toxic doses.

Mechanistic Rationale

1. Aggregate as BH3‑only scaffold – Amyloid and tau fibrils expose conserved hydrophobic grooves that can bind the BH3 α‑helix of pro‑apoptotic proteins with micromolar affinity, as shown for synthetic amyloid peptides binding BIM (see analogous studies on Aβ‑BIM interactions). In senescent cells, the burden of misfolded proteins promotes formation of such aggregates, effectively sequestering BH3‑only molecules away from Bcl‑2/MCL‑1.
2. NRF2‑Bcl‑2 axis amplifies dependence – NRF2 directly transactivates Bcl‑2, Bcl‑xL and MCL‑1 promoters [4] while also upregulating HSP70 and DNAJB6 chaperones that facilitate aggregate formation [3]. This creates a feed‑where: higher NRF

Hypothesis

Rapamycin extends lifespan by simultaneously triggering two opposing genomic effects: (1) autophagy‑dependent reduction of mitochondrial ROS that lowers oxidative DNA damage in non‑dividing cells, and (2) chronic mTORC1 inhibition that diminishes de novo dNTP synthesis, increasing replication stress and copy‑number variation (CNV) formation in proliferative compartments. The net longevity outcome depends on the tissue‑specific balance between these protective and mutagenic forces.

Mechanistic Basis

• ROS scavenging arm: Rapamycin activates ULK1‑dependent autophagy, clearing damaged mitochondria and decreasing superoxide production. Lower ROS reduces 8‑oxoguanine lesions, thereby diminishing the substrate for error‑prone repair that can generate CNVs 2. This mirrors caloric restriction’s direct enhancement of base excision repair and mitochondrial DNA stability.
• dNTP depletion arm: mTORC1 stimulates S6K1‑mediated phosphorylation of CAD, the rate‑limiting enzyme for de novo pyrimidine biosynthesis. Inhibition of mTORC1 lowers CAD activity, shrinking dNTP pools 6. In S‑phase, reduced dNTP availability stalls replication forks, elevating fork collapse and mis‑segregation events that produce CNVs 4.
• Tissue specificity: Post‑mitotic tissues (neurons, muscle) rely more on ROS mitigation than on high dNTP fluxes, so the protective arm dominates. In contrast, stem‑cell niches (intestinal cryp

Aged stem cells exhibit a paradox: global chromatin accessibility increases at many loci, yet specific functional enhancers close, impairing lineage‑appropriate gene expression. We hypothesize that this epigenetic remodeling creates a ordered hierarchy of enhancer loss that preferentially silences stress‑responsive selective autophagy receptors (SQSTM1/p62, OPTN, NBR1, CALCOCO2) while leaving core autophagy machinery promoters (ATG5, ATG7, BECN1) relatively intact. Consequently, bulk autophagosome formation persists but cargo‑specific clearance pathways—mitophagy, aggrephagy, lipophagy—fail in a predictable sequence, driving the accumulation of damaged mitochondria, protein aggregates, and lipid droplets that underlie stem‑cell exhaustion.

Mechanistic rationale

1. Promoter vs. enhancer vulnerability – Housekeeping autophagy genes often reside in CpG‑rich promoters that resist age‑related DNA methylation and nucleosome remodeling. In contrast, selective autophagy receptor genes depend on distal enhancers bound by stress‑activated transcription factors (TFs) such as FOXO3, NRF2, and TFEB. These enhancers are enriched for nucleosome‑sensitive motifs and are therefore more susceptible to the chromatin‑closing activity observed in aged HSCs and muscle satellite cells (see [1][2]).
2. TF occupancy as a sensor – In young stem cells, oxidative or metabolic stress triggers FOXO3/NRF2 nuclear translocation, enhancing receptor expression. With age, enhancer erosion reduces TF binding affinity, blunting this stress‑responsive burst. Consequently, basal autophagy (drive

Hypothesis

Administering the cognition‑enhancing strain Bifidobacterium breve A1 at the circadian phase when host BMAL1/CLOCK activity peaks (subjective daytime, ZT6) will synchronize microbial lactate production with the brain’s autophagic window, thereby amplifying microglial SIRT1‑dependent deacetylation of BMAL1 and reinforcing the circadian anti‑aging firewall. This chronobiotic timing should yield greater improvements in cognition and stronger suppression of hippocampal senescence than the same strain given at a mismatched phase (ZT18).

Mechanistic Rationale

1. B. breve A1 generates D‑lactate, which can cross the blood‑brain barrier and act as a signaling molecule that modulates neuronal excitability and microglial metabolism [1]. Lactate also serves as a zeitgeber for peripheral clocks by stabilizing HIF‑1α and enhancing BMAL1 transcription [2]
2. Microglial autophagic flux peaks during the early rest phase of the circadian cycle, driven by BMAL1‑dependent expression of LC3 and lysosomal genes [3]
3. SIRT1, a NAD⁺‑dependent deacetylase, links cellular energy status to clock function; its activation deacetylates BMAL1, increasing its transcriptional activity and promoting autophagy [4]
4. By delivering B. breve A1 when BMAL1/CLOCK drive is high, lactate‑induced SIRT1 activation will be timed to coincide with the micro

Hypothesis: GLI-Mediated Transcriptional Repression Drives Age-Dependent Autophagy Suppression

Persistent Hedgehog (Hh) ligand release from senescent stromal cells maintains low‑level SMO activity in aged parenchyma, favoring the accumulation of GLI2/GLI3 repressor forms (https://doi.org/10.1016/j.devcel.2015.03.009). These repressor GLIs recruit histone deacetylase complexes (HDAC1/2 and SIRT1) to the TFEB promoter, leading to H3K9 deacetylation and chromatin compaction that diminishes TFEB transcription (https://pmc.ncbi.nlm.nih.gov/articles/PMC4502732/). Concurrently, mTORC1 hyperactivation phosphorylates ULK1/ATG13 to block autophagy initiation (https://pmc.ncbi.nlm.nih.gov/articles/PMC6826502/). The combined transcriptional and post‑translational hits create a coordinated suppression of the autophagy‑lysosome pathway, which is not a simple loss‑of‑function but an active, reversible brake.

Testable predictions

1. In aged mouse liver or human fibroblasts, ChIP‑qPCR will show increased occupancy of GLI2/GLI3 and HDAC1/SIRT1 at the TFEB promoter compared with young controls.
2. Pharmacological inhibition of GLI DNA binding (GANT61) or CRISPRi‑mediated knock‑down of GLI2/GLI3 will raise TFEB mRNA and protein levels, restore nuclear TFEB translocation, and increase LC3‑II turnover in the presence of bafilomycin A1.
3. Restoring autophagy flux via GLI inhibition will reduce senescence‑associated secretory phenot

Adaptive mTOR inhibition guided by real‑time recovery signals offers a way to keep the civilization‑survival dial in the range where autophagy is upregulated without sacrificing the anabolic capacity needed for tissue repair. High heart‑rate variability (HRV) and deep sleep reflect a parasympathetic state that activates AMPK, which in turn phosphorylates TSC2 and suppresses mTORC1 activity, promoting autophagy and stress resistance [1][2]. Conversely, low HRV signals a sympathetic dominance that favors mTORC1‑driven protein synthesis for wound healing and immune defense [3]. By dosing rapamycin only when wearable‑derived HRV exceeds a personalized threshold (e.g., >70 ms RMSSD) and skipping doses when HRV falls below that threshold, we predict that intermittent mTORC1 suppression will be timed to periods when the organism is already biased toward survival mode, thereby amplifying autophagy without triggering the compensatory rebound that occurs with constant inhibition [4][5]. We can test this hypothesis in a crossover trial with two arms: (1) fixed low‑dose rapamycin (3 mg weekly) and (2) HRV‑adaptive rapamycin (same weekly total dose but administered only on days when overnight HRV exceeds the individual’s 75th percentile). Primary outcomes will be changes in circulating LC3‑II/I ratio (autophagy marker) and myofibrillar protein synthesis rate measured by deuterated leucine incorporation after a standardized resistance‑exercise bout. Secondary outcomes include lean‑mass change, illness‑free days, and self‑reported recovery scores. We expect the adaptive arm to show a ≥20 

Hypothesis: Intermittent fasting triggers TFEB‑mediated lysosomal biogenesis that preferentially eliminates senescent cells exhibiting a chronic SASP profile and high basal mTORC1 activity, while sparing transiently senescent hostage negotiators that maintain low mTORC1 signaling and rely on alternative survival pathways.

Rationale: Chronic senescent cells accumulate lysosomal damage and become dependent on lysosomal‑mediated autophagy for survival ([4]). Their SASP is enriched in IL‑6, CCL2 and MMPs, correlating with sustained mTORC1 signaling that drives TFEB cytoplasmic retention. In contrast, transient senescent fibroblasts in acute wounds display a PDGF‑AA‑rich SASP, low p‑S6K, and retain nuclear TFEB, allowing lysosomal priming without degradation ([1], [5]). A 20+ hour fasting window lowers systemic glucose and insulin, reducing mTORC1 activity via AMPK activation and promoting TFEB nuclear translocation (established). Nuclear TFEB upregulates lysosomal genes (LAMP1, CTSD) and enhances autophagic flux. We predict that chronic senescent cells, already primed for lysosomal dependence, will undergo lysosomal membrane permeabilization and caspase‑independent death upon TFEB‑driven lysosomal overload, whereas transient negotiators, with lower lysosomal load and intact TFEB nuclear residency, will resist this stress and continue to secrete PDGF‑AA to support repair.

Testable predictions: 1. In murine excisional wound models, mice subjected to 24‑hour fasts prior to injury will show a selective reduction of p16+/p21+ fibroblasts expressing IL‑6 and CCL2 (chron

Hypothesis

Aging is not merely a byproduct of declining selection; instead, epigenetic programs that activate the senescence-associated secretory phenotype (SASP) in post‑reproductive individuals are tuned to remodel the gut microbiome, thereby altering metabolite fluxes that enhance the survival and reproductive success of close kin.

Mechanistic Basis

Recent work shows that antagonistic pleiotropy drives trade‑offs between early fecundity and late‑life survival [2]. However, the conserved SASP—comprising IL‑6, MMPs, and other factors—can be modulated by nutrient‑sensing pathways such as mTOR and IGF‑1, which themselves respond to dietary cues [4]. We propose that, in many species, age‑dependent DNA‑methylation changes at promoters of SASP genes create a bistable switch: once reproductive output falls below a threshold, methylation declines, SASP expression rises, and secreted factors diffuse into the intestinal lumen. There, SASP components influence microbial community structure by inhibiting certain taxa and promoting others that produce short‑chain fatty acids (SCFAs) or vitamins beneficial to kin. This creates a feedback loop where the host’s physiological state shapes a microbial environment that preferentially supports related individuals sharing the same niche (e.g., offspring or siblings in the same burrow). Because the microbiome can be transmitted vertically or via close contact, the SASP‑driven shift confers a group‑level advantage without requiring direct group selection; individual fitness is increased indirectly through kin survival.

Testable Predi

Hypothesis

Berberine’s systemic activation of AMPK and inhibition of PCSK9 are primarily indirect effects driven by microbiota‑altered bile acid pools, not by direct berberine action on hepatocytes or other peripheral tissues.

Mechanistic Rationale

Berberine’s low oral bioavailability (<5%) confines its highest concentrations to the intestinal lumen, where it reshapes the gut microbiome [3]. One consistent shift is the suppression of bacterial bile‑salt hydrolase (BSH) activity, leading to an accumulation of unconjugated primary bile acids and a relative increase in secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) after microbial 7α‑dehydroxylation [5]. These bile acids act as signaling ligands for the membrane receptor TGR5 and the nuclear receptor FXR, both highly expressed in intestinal enteroendocrine cells and hepatocytes.

Activation of TGR5 stimulates cAMP production, which can activate AMPK via upstream kinases (LKB1, CaMKKβ) in a cAMP‑PKA‑dependent manner. FXR activation, meanwhile, represses PCSK9 transcription through SHP‑mediated inhibition of HNF1α, mirroring berberine’s direct effect on HNF1α destabilization [2] but occurring downstream of bile‑acid signaling. Importantly, SCFAs produced by the remodeled microbiota can also engage GPR41/43, yet their systemic concentrations are often insufficient to account for the magnitude of AMPK activation observed; bile acids, by contrast, reach micromolar levels in the portal circulation after microbial modification.

Thus, berberine initiates a gut‑centric cascade: antimicrobial modu

Hypothesis

Age‑related deterioration of hypothalamic autonomic nuclei and vagal efferent output reduces acetylcholine‑dependent signaling to the gut vasculature, leading to mesenteric arterial stiffening, elastin fragmentation, and systemic propagation of vascular aging.

Mechanistic Rationale

Central autonomic circuits regulate gut blood flow via cholinergic motor neurons that release acetylcholine onto intestinal smooth muscle and endothelial cells (, 2026)【4】. In aging, hypothalamic NF‑κB activation diminishes parasympathetic tone【5】, while vagal efferent fibers show dystrophic loss【3】. Acetylcholine normally suppresses NF‑κB in vascular endothelium and stimulates elastin‑preserving pathways through muscarinic M3 receptors. Loss of this tonic inhibition permits chronic low‑grade inflammation, oxidative stress, and matrix metalloproteinase activation in the mesenteric artery wall, accelerating calcification and stiffening. Stiff mesenteric vasculature elevates pulse pressure transmitted to the portal system, impairing nutrient flux and gut barrier integrity, which then feeds back to aggravate brain inflammation via afferent vagal signals—a vicious loop that inverts the typical gut‑→‑brain causality.

Testable Predictions

1. Old mice with selective chemogenetic activation of hypothalamic parasympathetic nuclei will exhibit restored vagal efferent firing, increased intestinal acetylcholine levels, and reduced mesenteric arterial stiffness compared with age‑matched controls.
2. Pharmacological blockade of muscarinic M3 receptors in the gut will abolish the protec

Hypothesis

Repeated expression of the OSK factors in aged female mice reverses age‑related erosion of X chromosome inactivation (XCI) by restoring DNA methylation at the inactive X, thereby silencing genes that escape with age and improving healthspan metrics; the same treatment does not significantly alter XCI in males because they lack a second X chromosome to stabilize.

Mechanistic reasoning

XCI maintenance depends on dense CpG methylation of the inactive X chromosome, a mark that becomes variably lost with age, permitting transcriptional escape of loci involved in synaptic function, signaling and myelin integrity 1 2. OSK induces a global epigenetic reset reminiscent of early embryonic reprogramming, during which DNMT3A/B are recruited to nascent inactive X chromosomes through direct interaction with XIST RNA. We propose that transient OSK expression re‑engages this DNMT3A/B‑XIST axis, depositing de novo methylation on CpGs that have drifted toward hypomethylation, thus re‑establishing silencing of escapees.

Because females possess two X chromosomes, restoring methylation on the inactive copy creates a buffering effect: deleterious alleles on the active X can be masked by the reactivated silent copy, enhancing robustness of stress‑response and immune networks. Males, with a single X, lack this redundant layer; OSK‑driven methylation changes would affect only the sole X and therefore cannot generate a comparable compensatory benefit, predicting a sex‑divergent out

Hypothesis

In the aging intestine, senescent epithelial cells are not uniformly harmful; they exhibit a temporal switch from barrier‑protective to barrier‑disruptive phenotypes. Early‑stage senescence triggered by sublethal stress (e.g., oxidative bursts, transient microbiota shifts) releases a SASP enriched in IFN‑γ‑low, IL‑6‑moderate, and exosomal miR‑200c that promotes claudin‑2‑mediated epithelial restitution and tight‑junction reassembly. As senescence persists, the same cells shift toward a classic pro‑inflammatory SASP (IL‑1β, IL‑6, TNF‑α, elevated miR‑191‑5p) that drives ZO‑1 loss, occludin endocytosis, and claudin‑2 over‑expression, culminating in leaky barrier. Thus, the net effect of senescent cells on intestinal permeability depends on their duration and the balance of SASP components.

Mechanistic rationale

1. Initial protective wave – Stress‑induced p16^INK4A^ activation in epithelial cells leads to a limited SASP that includes exosomal miR‑200c. miR‑200c targets ZEB1/2, relieving repression of occludin and JAM‑A transcription, while modest IL‑6 upregulates claudin‑2 just enough to increase paracellular water flux, facilitating epithelial migration during injury repair 1.
2. Switch to pathogenic SASP – Continued DNA damage and telomere attrition activate NF‑κB p65 and reduce CB₁ signaling, elevating miR‑191‑5p. miR‑191‑5p directly suppresses ZO‑1 mRNA, while heightened IL‑1β and TNF‑α promote occludin endocytosis and JAM‑A internalization. The resulting tight‑junction remodeling favors a leak

Hypothesis

We propose that age‑associated 4‑hydroxynonenal (4‑HNE) adducts on tropoelastin fragments act as endogenous danger signals that bind Toll‑like receptors (TLR2/4) on vascular smooth muscle cells, triggering a signaling cascade that amplifies oxidative stress, promotes VSMC osteogenic transdifferentiation, and increases release of calcification‑competent extracellular vesicles (EVs). Simultaneously, elevated intracellular acetyl‑CoA, generated by heightened metabolic activity, acetylates histones at osteogenic gene promoters (RUNX2, MSX2, ALP), locking in the calcific phenotype. This dual hit— receptor‑mediated inflammation plus metabolic‑epigenetic reprogramming— converts elastin degradation products into active drivers of arterial calcification, challenging the view that elastin loss is merely a passive structural deficit.

Mechanistic Rationale

• 4‑HNE adducts accumulate with age in aortic tissue, predominantly within VSMCs [4]. These adducts can modify lysine residues on elastin‑derived peptides, creating neo‑epitopes recognized by pattern‑recognition receptors.
• TLR engagement activates NF‑κB and MAPK pathways, raising ROS production and further stimulating BMP/Smad signaling, which is known to induce VSMC osteogenic markers (RUNX2, MSX2, ALP) [1].
• Osteogenic VSMCs shed EVs enriched in annexin A6, phosphatases, and collagen fragments that serve as nucleating foci for hydroxyapatite crystal formation [2].
• Increased glycolytic flux and acetate production raise acetyl‑CoA levels; acetyl‑CoA‑dependent histone acetylation enhances transcription of osteog

Hypothesis

In healthy adults, aligning a medium‑duration cold plunge (10‑15 min at 5‑10°C) to occur during the early slow‑wave sleep window—identified in real‑time by wearable‑derived HRV and sleep staging—will amplify insulin‑independent GLUT4 translocation and glycogen synthase activity when paired with an evening carbohydrate bolus guided by continuous glucose monitoring (CGM) to maintain post‑prandial glucose between 80‑110 mg/dL. This combined protocol is expected to increase overnight muscle glycogen storage by ≥15% relative to either intervention alone, improve next‑day fasting glucose tolerance, and boost subjective recovery metrics.

Rationale

• Wearable‑driven personalization of sleep interventions shows promise but lacks supplement or physiological coupling data[1][3].
• Cold plunge at 5‑10°C reduces creatine kinase and inflammation while triggering norepinephrine release that activates AMPK‑PGC‑1α pathways, promoting mitochondrial biogenesis and GLUT4 mobilization[5][2]
• Evening carbohydrate intake augments glycogen synthase activity; however, unchecked spikes can impair nocturnal fat oxidation and next‑day glucose tolerance[9][10]
• CGM‑guided carb cycling remains

Hypothesis: Cyclic Yamanaka factor expression rejuvenates the SASP switch of senescent fibroblasts to restore acute hostage negotiator function

Core idea Transient, cyclic OSKM expression in aged tissue does not merely clear senescent cells; it reprograms their chromatin landscape to reinstate the early‑phase, regenerative SASP that defines successful senescence‑mediated negotiation. When this SASP switch is restored, senescent fibroblasts again recruit pro‑healing immune subsets and stimulate myofibroblast differentiation without persisting into a chronic, inflammatory state.

Mechanistic rationale Aging erodes the dynamic enhancer circuitry that governs the SASP timing. Young senescent fibroblasts exhibit open chromatin at enhancers driving PDGF‑AA, VEGF‑A, and TGF‑β1, while keeping NF‑κB‑dependent IL‑6 and IL‑1β loci in a poised but repressed state. In aged fibroblasts these enhancers become methylated and lose accessibility, biasing the SASP toward a constitutively inflammatory profile. Cyclic OSKM expression is known to transiently elevate nucleosome remodeling and DNA demethylation activity, which could re‑open regenerative enhancers and simultaneously recruit repressive complexes (e.g., HDAC3) to inflammatory loci. The result would be a restored temporal SASP: an early burst of pro‑regenerative factors followed by timely attenuation as the cell prepares for immune clearance.

Testable predictions

• In aged mouse skin, cyclic OSKM (e.g., 2 days on/5 days off for 4 weeks) will increase the proportion of p16⁺ fibroblasts that display a young‑like ATA

Hypothesis

Loss of heparan sulfate proteoglycans (HSPGs) in aging Bruch's membrane not only diminishes Factor H binding but also unmasks cryptic binding sites on collagen IV that directly initiate the alternative complement pathway. These exposed sites recruit Factor B and properdin, forming C3 convertase (C3bBb) independent of classical or lectin routes. The resulting C3b deposition amplifies local C3 synthesis in retinal pigment epithelium (RPE) via a complement‑triggered NF‑κB loop, creating a self‑reinforcing micro‑environment that drives drusen formation and RPE stress.

Mechanistic Reasoning

1. HSPG loss reduces steric hindrance and alters electrostatic shielding of collagen IV fibrils.
2. Exposed collagen IV domains (e.g., the COL1 region) possess high affinity for Factor B, as shown in extracellular matrix models.
3. Factor B binding stabilizes the C3bBb convertase, leading to sustained C3 cleavage and C3b amplification.
4. Elevated C3a and C5a engage receptors on RPE, activating NF‑κB and upregulating C3 transcription.
5. Increased intracellular C3 feeds back to amplify complement activation at the RPE‑Bruch's interface, establishing a vicious cycle.

Testable Predictions

• Prediction 1: In aged mouse eyes or human donor Bruch's membrane with validated HSPG loss, collagen IV fragments will co‑immunoprecipitate with Factor B and properdin more intensely than in young tissue.
• Prediction 2: Enzymatic restoration of HSPG sulfation using heparan sulfate mimetics will decrease collagen IV–Factor B interaction and lower C3b deposition in ex‑vivo choroi

Hypothesis

Aging disrupts the spatial balance of mTOR activity: hematopoietic stem cells (HSCs) develop chronic mTORC1 hyperactivity that pushes them toward myeloid differentiation and exhausts their lymphoid/erythroid potential, while endothelial and stromal niche cells suffer mTORC1 decline, losing the capacity to sustain vascular integrity and secrete erythropoiesis‑supporting factors. We propose that the net erythropoietic output in aged marrow is determined not by the absolute mTOR level in either compartment, but by the ratio of HSC‑intrinsic mTOR activity to niche‑cell mTOR activity. When this ratio exceeds a threshold, erythropoiesis collapses despite normal circulating EPO, because HSCs are locked in a proliferative, differentiation‑biased state and the niche cannot provide the oxygen‑sensing and stromal cues required for effective EPO signaling.

Mechanistic Rationale

1. HSC‑intrinsic mTORC1 drives a transcriptional program that upregulates CDK inhibitors (p21^Cip1^, p27^Kip1^) and biases metabolism toward glycolysis, reducing responsiveness to EPO‑mediated STAT5 phosphorylation [1].
2. Endothelial mTORC1 maintains VEGF‑A production and capillary perfusion; its decline lowers marrow pO2, diminishing the hypoxia‑inducible factor‑2α (HIF‑2α) drive for EPO synthesis and impairing EPO receptor (EPOR) trafficking to the membrane of erythroid progenitors [2]
3. **Stromal mesenchymal cells require mTO

Hypothesis

Age‑related loss of protein persulfidation promotes aberrant liquid‑liquid phase separation (LLPS) of specific intrinsically disordered proteins (IDPs). These condensates sequester subunits of the TRiC/CCT chaperone complex, reducing its availability for folding nascent polypeptides and mitochondrial assembly factors. Consequently, TRiC deficiency leads to misassembly of electron‑transport‑chain complexes I and IV, reproducing the interactome and respiration defects observed in aged mouse skeletal muscle.

Mechanistic Basis

Persulfidation modifies cysteine residues on many IDPs, keeping them soluble and preventing sticky interactions. Recent work shows endogenous protein persulfidation declines with age [3], coinciding with increased LLPS propensity. TRiC is known to prevent aggregation of client proteins and is preserved in cognitively healthy centenarians [4]. If persulfidation loss drives IDPs into LLPS droplets that trap TRiC, the chaperone’s network connectivity drops, mirroring the universal decline of ATP‑dependent chaperone PPI specificity reported in aging [2]. Sequestered TRiC cannot assist the folding of mitochondrial import factors and ETC subunits, leading to the specific disruptions in complex I and IV assembly, glutamate dehydrogenase activity, and CoA‑binding enzymes identified by XL‑MS [1]. This links a molecular‑scale PTM defect to organelle‑scale inte

Hypothesis

Structured evening darkness, defined as uninterrupted exposure to illuminance below 1 lux for at least 4 hours before habitual bedtime, restores nocturnal melatonin amplitude and downstream neuroprotective signaling more effectively than intermittent blue‑light filtering alone.

Mechanistic Basis

Evening light suppresses melatonin via melanopsin‑expressing retinal ganglion cells whose activation threshold is intensity‑dependent, not wavelength‑specific [4]. When illuminance stays below the melanopic suppression threshold (~10 lux at 490 nm), melatonin secretion follows its natural rise, supporting antioxidant activity, BDNF transcription, and microglial quiescence [7]. Bright light, even if filtered to remove short wavelengths, still delivers sufficient photons to activate melanopsin if intensity remains high, explaining the null effect of blue‑blocking glasses in trials [1]. Therefore, the key variable is irradiance, not spectral composition.

We propose that extending darkness triggers a cascade: elevated melatonin scavenges free radicals, reduces NF‑κB signaling, lowers IL‑6 and TNF‑α, and thereby lifts inhibition on hippocampal BDNF expression. Increased BDNF promotes synaptic plasticity and neurogenesis, counteracting the cognitive deficits observed under chronic dim‑night light [6].

Testable Predictions

1. In a crossover study, participants receiving 4‑hour darkness (<1 lux) from 20:00 to 00:00 will show a ≥25% increase in area‑under‑the‑curve melatonin salivary levels compared to evenings with standard room lighting (~100 lux) while wearing comme